268 related articles for article (PubMed ID: 33847763)
1. Cytokine signaling convergence regulates the microglial state transition in Alzheimer's disease.
Lau SF; Fu AKY; Ip NY
Cell Mol Life Sci; 2021 May; 78(10):4703-4712. PubMed ID: 33847763
[TBL] [Abstract][Full Text] [Related]
2. Receptor-ligand interaction controls microglial chemotaxis and amelioration of Alzheimer's disease pathology.
Lau SF; Fu AKY; Ip NY
J Neurochem; 2023 Sep; 166(6):891-903. PubMed ID: 37603311
[TBL] [Abstract][Full Text] [Related]
3. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
[TBL] [Abstract][Full Text] [Related]
4. 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner.
Wong MY; Lewis M; Doherty JJ; Shi Y; Cashikar AG; Amelianchik A; Tymchuk S; Sullivan PM; Qian M; Covey DF; Petsko GA; Holtzman DM; Paul SM; Luo W
J Neuroinflammation; 2020 Jun; 17(1):192. PubMed ID: 32552741
[TBL] [Abstract][Full Text] [Related]
5. Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer's disease.
Terzioglu G; Young-Pearse TL
Mol Neurodegener; 2023 Nov; 18(1):89. PubMed ID: 38017562
[TBL] [Abstract][Full Text] [Related]
6. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
[TBL] [Abstract][Full Text] [Related]
7. SOCS1 Mediates Berberine-Induced Amelioration of Microglial Activated States in N9 Microglia Exposed to
Guo Q; Wang C; Xue X; Hu B; Bao H
Biomed Res Int; 2021; 2021():9311855. PubMed ID: 34778460
[TBL] [Abstract][Full Text] [Related]
8. TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease.
Yang J; Wise L; Fukuchi KI
Front Immunol; 2020; 11():724. PubMed ID: 32391019
[TBL] [Abstract][Full Text] [Related]
9. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice.
Hickman SE; Allison EK; El Khoury J
J Neurosci; 2008 Aug; 28(33):8354-60. PubMed ID: 18701698
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer's Disease.
Zhang Y; Zhao Y; Zhang J; Yang G
Neurochem Res; 2020 Nov; 45(11):2560-2572. PubMed ID: 32929691
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory factors and amyloid β-induced microglial polarization promote inflammatory crosstalk with astrocytes.
Xie L; Zhang N; Zhang Q; Li C; Sandhu AF; Iii GW; Lin S; Lv P; Liu Y; Wu Q; Yu S
Aging (Albany NY); 2020 Nov; 12(22):22538-22549. PubMed ID: 33196457
[TBL] [Abstract][Full Text] [Related]
12. Donepezil Regulates LPS and Aβ-Stimulated Neuroinflammation through MAPK/NLRP3 Inflammasome/STAT3 Signaling.
Kim J; Lee HJ; Park SK; Park JH; Jeong HR; Lee S; Lee H; Seol E; Hoe HS
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638977
[TBL] [Abstract][Full Text] [Related]
13. Soluble Aβ oligomers and protofibrils induce NLRP3 inflammasome activation in microglia.
Lučiūnaitė A; McManus RM; Jankunec M; Rácz I; Dansokho C; Dalgėdienė I; Schwartz S; Brosseron F; Heneka MT
J Neurochem; 2020 Dec; 155(6):650-661. PubMed ID: 31872431
[TBL] [Abstract][Full Text] [Related]
14. NLRP1 Inflammasome Activation in the Hippocampal Formation in Alzheimer's Disease: Correlation with Neuropathological Changes and Unbiasedly Estimated Neuronal Loss.
Španić E; Langer Horvat L; Ilić K; Hof PR; Šimić G
Cells; 2022 Jul; 11(14):. PubMed ID: 35883667
[TBL] [Abstract][Full Text] [Related]
15. Differential pathways for interleukin-1β production activated by chromogranin A and amyloid β in microglia.
Wu Z; Sun L; Hashioka S; Yu S; Schwab C; Okada R; Hayashi Y; McGeer PL; Nakanishi H
Neurobiol Aging; 2013 Dec; 34(12):2715-25. PubMed ID: 23831373
[TBL] [Abstract][Full Text] [Related]
16. Microglia in Alzheimer's Disease: A Favorable Cellular Target to Ameliorate Alzheimer's Pathogenesis.
Sumsuzzman DM; Uddin MS; Kabir MT; Hasana S; Perveen A; Alanazi IS; Albadrani GM; Abdel-Daim MM; Ashraf GM
Mediators Inflamm; 2022; 2022():6052932. PubMed ID: 35693110
[TBL] [Abstract][Full Text] [Related]
17. IL-33-PU.1 Transcriptome Reprogramming Drives Functional State Transition and Clearance Activity of Microglia in Alzheimer's Disease.
Lau SF; Chen C; Fu WY; Qu JY; Cheung TH; Fu AKY; Ip NY
Cell Rep; 2020 Apr; 31(3):107530. PubMed ID: 32320664
[TBL] [Abstract][Full Text] [Related]
18. Inflammasome activation under high cholesterol load triggers a protective microglial phenotype while promoting neuronal pyroptosis.
de Dios C; Abadin X; Roca-Agujetas V; Jimenez-Martinez M; Morales A; Trullas R; Mari M; Colell A
Transl Neurodegener; 2023 Mar; 12(1):10. PubMed ID: 36895045
[TBL] [Abstract][Full Text] [Related]
19. Microglia and Alzheimer's Disease.
Merighi S; Nigro M; Travagli A; Gessi S
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361780
[TBL] [Abstract][Full Text] [Related]
20. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
